Enhance your understanding of emerging therapies and the evolving science behind cardiometabolic clinical trials. Learn how to interpret current data, support diverse patient participation, and apply new evidence to improve outcomes in your clinical practice.
Learning Objectives
- Define the significance of clinical trials in advancing treatment for cardio-metabolic diseases such as diabetes, hypertension, and dyslipidemia
- Describe the efficacy and safety profiles of emerging therapies based on current clinical trial data
- Discuss key components of designing robust cardio-metabolic clinical trials, including patient recruitment, patient diversity, endpoints, and the role of the CV nurse
CE certificate available upon successful completion of the post-test and program evaluation.
Accreditation:
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.
